{'output': [['Protalix Biotherapeutics Inc.', 'ORG', 'Reports', 'Positive Interim Data', 'CONCEPT'], ['Protalix Biotherapeutics Inc.', 'ORG', 'Operate_In', 'Pharmaceutical Industry', 'SECTOR'], ['Protalix Biotherapeutics Inc.', 'ORG', 'Produce', 'Oprx-106', 'PRODUCT'], ['Oprx-106', 'PRODUCT', 'Impact', 'Patients with Ulcerative Colitis', 'GPE'], ['Oprx-106', 'PRODUCT', 'Tolerated', 'Well', 'CONCEPT'], ['Oprx-106', 'PRODUCT', 'Relate_To', 'Adverse Events', 'CONCEPT'], ['Protalix Biotherapeutics Inc.', 'ORG', 'Expects', 'Report Full Results', 'CONCEPT'], ['Protalix Biotherapeutics Inc.', 'ORG', 'Expects', 'End of Q1 2018', 'TIME']]}